Giseli Furlan Correa

Giseli Furlan Correa

Auto-generated profile, based on publicly available information

Giseli Furlan Correa

Basic and Applied Immunology Program, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo 14049-900, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
NMNúbia Sabrina Martins
Núbia Sabrina Martins
Thais Fernanda de Campos Fraga-SilvaThais Fernanda de Campos Fraga-Silva
Thais Fernanda de Campos Fraga-Silva
GCGiseli Furlan Correa
Giseli Furlan Correa
MBMèdéton Mahoussi Michaël Boko
Mèdéton Mahoussi Michaël Boko
LRLeandra Ramalho
Leandra Ramalho
VBVania Luiza Deperon Bonato
Vania Luiza Deperon Bonato
Propolis is a natural product produced by bees that is primarily used in complementary and alternative medicine and has anti-inflammatory, antibacterial, antiviral, and antitumoral biological properties. Some studies have reported the beneficial effects of propolis in models of allergic asthma. In a previous study, our group showed that green propolis treatment reduced airway inflammation and mucus secretion in an ovalbumin (OVA)-induced asthma model and resulted in increased regulatory T cells (Treg) and polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) frequencies in the lungs, two leukocyte populations that have immunosuppressive functions. In this study, we evaluated the anti-inflammatory effects of artepillin C (ArtC), the major compound of green propolis, in the context of allergic airway inflammation. Our results show that ArtC induces in vitro differentiation of Treg cells and monocytic MDSC (M-MDSC). Furthermore, in an OVA-induced asthma model, ArtC treatment reduced pulmonary inflammation, eosinophil influx to the airways, mucus and IL-5 secretion along with increased frequency of M-MDSC, but not Treg cells, in the lungs. Using an adoptive transfer model, we confirmed that the effect of ArtC in the reduction in airway inflammation was dependent on M-MDSC. Altogether, our data show that ArtC exhibits an anti-inflammatory effect and might be an adjuvant therapy for allergic asthma.

31 October 2023 in iScience
Verified
Journal Article
Open access
TFThais F.C. Fraga-Silva
Thais F.C. Fraga-Silva
UCUalter G. Cipriano
Ualter G. Cipriano
MFMarcilio Fumagalli
Marcilio Fumagalli
GCGiseli F. Correa
Giseli F. Correa
CFCarlos Fuzo
Carlos Fuzo
VBVania Luiza Deperon Bonato
Vania Luiza Deperon Bonato
Airway epithelial cells (AEC) infected with SARS-CoV-2 may drive the dysfunction of macrophages during COVID-19. We hypothesized that the direct interaction of AEC with macrophages mediated by CD95/CD95L or indirect interaction mediated by IL-6 signaling are key steps for the COVID-19 severe acute inflammation. The interaction of macrophages with apoptotic and infected AEC increased CD95 and CD163 expression, and induced macrophage death. Macrophages exposed to tracheal aspirate with high IL-6 levels from intubated patients with COVID-19 or to recombinant human IL-6 exhibited decreased HLA-DR expression, increased CD95 and CD163 expression and IL-1β production. IL-6 effects on macrophages were prevented by both CD95/CD95L antagonist and by IL-6 receptor antagonist and IL-6 or CD95 deficient mice showed significant reduction of acute pulmonary inflammation post-infection. Our findings show a non-canonical CD95L-CD95 pathway that simultaneously drives both macrophage activation and dysfunction and point to CD95/CD95L axis as therapeutic target.

3 January 2023 in The Journal of Pathology
Verified
Journal Article
Closed access
SASandra P Palma Albornoz
Sandra P Palma Albornoz
Thais Fernanda de Campos Fraga-SilvaThais Fernanda de Campos Fraga-Silva
Thais Fernanda de Campos Fraga-Silva
RCRenan Vh de Carvalho
Renan Vh de Carvalho
TRTamara S Rodrigues
Tamara S Rodrigues
AGAna Flávia Gembre
Ana Flávia Gembre
VBVania Luiza Deperon Bonato
Vania Luiza Deperon Bonato

22 August 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
Thais Fernanda de Campos Fraga-SilvaThais Fernanda de Campos Fraga-Silva
Thais Fernanda de Campos Fraga-Silva
UCUalter G. Cipriano
Ualter G. Cipriano
MFMarcilio Fumagalli
Marcilio Fumagalli
GCGiseli F. Correa
Giseli F. Correa
CFCarlos Fuzo
Carlos Fuzo
VBVania Luiza Deperon Bonato
Vania Luiza Deperon Bonato
Airway epithelial cells (AEC) are the first in contact with SARS-CoV-2 and drive the interface with macrophage to generate inflammation. To elucidate how those initial events contribute to the immunopathology or to dysregulate the immune response observed in severe and critical COVID-19, we determined the direct and indirect interactions of these cells. AEC lineage (Calu-3) infected with SARS-CoV-2 and epithelial cells (CD45 - EpCAM + ) from intubated COVID-19 patients showed high expression of CD95L. Infected-Calu-3 cells secreted IL-6, and expressed annexin V and caspase-3, apoptosis markers. The direct interaction of macrophages with sorted apoptotic Calu-3 cells, driven by SARS-CoV-2 infection, resulted in macrophage death and increased expression of CD95, CD95L and CD163. Macrophages exposed to tracheal aspirate supernatants from intubated COVID-19 patients or to recombinant human IL-6 exhibited decreased HLA-DR and increased CD95 and CD163 expression. IL-6 effects on macrophages were prevented by tocilizumab (anti-IL-6 receptor mAb) and Kp7-6 (CD95/CD95L antagonist). Similarly, lung inflammation and death of AEC were decreased in CD95 and IL-6 knockout mice infected with SARS-CoV-2. Our results show that the AEC-macrophage interaction via CD95/CD95L signaling is an initial key step of immunopathology of severe COVID-19 and should be considered as a therapeutic target. Abstract Figure: Highlights: - SARS-CoV-2-infected airway epithelial cells (AEC) secrete IL-6, express Fas/FasL and undergo apoptosis; - SARS-CoV-2-infected apoptotic AEC induces Fas/FasL expression and death in macrophages; - IL-6 induces IL-1β secretion, reduction of HLA-DR and increase of Fas and CD163 expression in macrophages; - Blockade of IL-6 signaling and Fas/FasL restores the expression of HLA-DR and reduces the expression of Fas and CD163, and secretion of IL-1β on isolated macrophages; in vivo, the deficiency of Fas and IL-6 decreases acute pulmonary inflammation in SARS-CoV-2-infected mice.